NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia

Documenti analoghi

• High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse
  di: Shalapour, Shabnam, et al.
  Pubblicazione: (2011)
• Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia
  di: Karawajew, Leonid, et al.
  Pubblicazione: (2015)
• Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia
  di: Barz, Malwine J., et al.
  Pubblicazione: (2020)
• High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
  di: Cario, Gunnar, et al.
  Pubblicazione: (2014)
• The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse
  di: Bandapalli, Obul R., et al.
  Pubblicazione: (2014)